Holger Sültmann

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Venues

Cancers

Molecular cancer research : MCR

Diagnostics (Basel, Switzerland)

NPJ precision oncology

German Cancer Research Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

German Cancer Research Center

Germany

Group Head / University Professor :: Cancer Genome Research

German Cancer Research Center

Germany

Assistant Professor :: Molecular Genome Analysis

Max-Planck-Institute for Biology

Germany

Postdoc and Assistant Professor :: Immunogenetics

Max-Planck-Institute for Biology

Germany

PhD :: Immunogenetics

Publications

Magdalena Goertz, Joanne Nyaboe Nyarangi-Dix, Lars Pursche, Viktoria Schütz, Philipp Reimold, Constantin Schwab, Albrecht Stenzinger, Holger Sültmann, Stefan Duensing, Heinz-Peter Schlemmer, David Bonekamp, Markus Hohenfellner, Jan Philipp Radtke
Impact of Surgeon's Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores. Cancers 14 (4) (2022)
Arlou Kristina Angeles, Florian Janke, Simone Bauer, Petros Christopoulos, Anja Lisa Riediger, Holger Sültmann
Liquid Biopsies beyond Mutation Calling: Genomic and Epigenomic Features of Cell-Free DNA in Cancer. Cancers 13 (22) (2021)
Arlou Kristina Angeles, Petros Christopoulos, Zhao Yuan, Simone Bauer, Florian Janke, Simon John Ogrodnik, Martin Reck, Matthias Schlesner, Michael Meister, Marc A Schneider, Steffen Dietz, Albrecht Stenzinger, Michael Thomas, Holger Sültmann
Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis. NPJ precision oncology 5 (1) (2021)
Simone Bauer, Leonie Ratz, Doreen Heckmann-Nötzel, Adam Kaczorowski, Markus Hohenfellner, Glen Kristiansen, Stefan Duensing, Peter Altevogt, Sabine M Klauck, Holger Sültmann
miR-449a Repression Leads to Enhanced NOTCH Signaling in TMPRSS2:ERG Fusion Positive Prostate Cancer Cells. Cancers 13 (5) (2021)
Arlou Kristina Angeles, Doreen Heckmann, Niclas Flosdorf, Stefan Duensing, Holger Sültmann
The ERG-Regulated LINC00920 Promotes Prostate Cancer Cell Survival via the 14-3-3ε-FOXO Pathway. Molecular cancer research : MCR 18 (10) (2020)
Petros Christopoulos, Steffen Dietz, Martina Kirchner, Anna-Lena Volckmar, Volker Endris, Olaf Neumann, Simon Ogrodnik, Claus-Peter Heussel, Felix J Herth, Martin Eichhorn, Michael Meister, Jan Budczies, Michael Allgäuer, Jonas Leichsenring, Tomasz Zemojtel, Helge Bischoff, Peter Schirmacher, Michael Thomas, Holger Sültmann, Albrecht Stenzinger
Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival. Cancers 11 (1) (2019)
Steffen Dietz, Petros Christopoulos, Lisa Gu, Anna-Lena Volckmar, Volker Endris, Zhao Yuan, Simon J Ogrodnik, Tomasz Zemojtel, Claus-Peter Heussel, Marc A Schneider, Michael Meister, Thomas Muley, Martin Reck, Matthias Schlesner, Michael Thomas, Albrecht Stenzinger, Holger Sültmann
Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer. Cold Spring Harbor molecular case studies 5 (6) (2019)
Arlou Kristina Angeles, Simone Bauer, Leonie Ratz, Sabine M Klauck, Holger Sültmann
Genome-Based Classification and Therapy of Prostate Cancer. Diagnostics (Basel, Switzerland) 8 (3) (2018)
Steffen Dietz, Aviezer Lifshitz, Daniel N Kazdal, Alexander Harms, Volker Endris, Hauke Winter, Albrecht Stenzinger, Arne Warth, Martin Sill, Amos Tanay, Holger Sültmann
Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas. International journal of cancer 144 (5) (2018)

Holger Sültmann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Holger Sültmann